Use of opioid painkillers for abdominal pain has more than doubled

Across U.S. outpatient clinics between 1997 and 2008, opioid prescriptions for chronic abdominal pain more than doubled, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association.

Chronic abdominal pain is a common symptom and a frequent reason for health-care visits. Because it is often incurable, clinicians often find it challenging to help their patients manage their abdominal pain over time.

"Opioid use for persistent abdominal pain highlights the growing challenges clinicians face trying to manage without the time, infrastructure and incentives needed to take the integrated approach that experts suggest," said Spencer D. Dorn, MD, MPH, of the University of North Carolina and lead author of the study. "Writing a prescription for a may be the path of least resistance; doing so may satisfy the patient's demand for relief and mitigate the clinician's possible feelings of inadequacy."

The researchers concluded that the dramatic nationwide rise in opioid use to treat chronic abdominal pain is concerning for several reasons. First, using opioids to treat non-cancer chronic pain is supported by very limited evidence. Second, opioids are frequently misused and sometimes abused. Finally, when used over long periods of time, opioids may trigger other , such as constipation, , and may even paradoxically worsen abdominal pain.

The researchers speculate that the growth in opioid use has likely been driven by numerous factors, including a tendency to generalize recommendations for the use of opioids in treating pain, campaigns to recognize pain as the "fifth vital sign," and widespread direct-to-consumer advertising, which, in the case of OxyContin, was considered misleading and illegal.

add to favorites email to friend print save as pdf

Related Stories

Take care with pain meds

Nov 11, 2011

Patients who are dependent on opioids (narcotic pain relievers) for pain management before knee replacement surgery have much more difficulty recovering, a study recently published in the Journal of Bone and Joint Surgery (JBJS) ...

Recommended for you

Boxed warnings are common in novel therapeutics

Aug 19, 2014

(HealthDay)—Boxed warnings are common on recent drug approvals, and many occur years after approval, according to a research letter published online Aug. 15 in JAMA Internal Medicine.

AstraZeneca says DOJ closes probe into drug trial

Aug 19, 2014

British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation into a clinical trial of the company's blood thinner Brilinta, and plans no further action.

Perampanel for epilepsy: Still no proof of added benefit

Aug 19, 2014

The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In a new early benefit assessment ...

User comments